$55.0M
The Oxford spinout secured backing from a group of healthcare investors to scale its EchoGo heart disease detection technology.
Ultromics
Ultromics develops artificial intelligence tools to detect hidden heart disease.
$78.7MTotal raised
An artificial intelligence health technology company that develops automated diagnostic platforms for cardiology.
Categories
Founders
Ross Upton
Founder
Ross leads Ultromics as founder, chief executive, and chief scientific officer while maintaining a research role at the University of Oxford. He also contributes to committees at the National Institutes of Health.
LinkedInInvestors
- $55.0M
- £23.7M
Funding history
£23.7M
The Series B round was led by the Blue Venture Fund to accelerate the deployment of artificial intelligence in echocardiography.